Methoxymethane

Methoxymethane

SCHEMBL30701424

CCCCCCCCCCCCSC(=S)SC(C)(C)C(=O)O.COC

nearest known ligand 0.38

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HSD17B10 Q99714 2/20 0.38
GMNN O75496 1/20 0.38
TP53 P04637 1/20 0.38
POLB P06746 1/20 0.38
MAPT P10636 1/20 0.38
THRB P10828 1/20 0.38
CYP2C9 P11712 1/20 0.38
BLM P54132 1/20 0.38
ACHE P22303 3/20 0.36
FAAH O00519 4/20 0.34
CES1 P23141 4/20 0.34
ALDH1A1 P00352 4/20 0.34
CES2 O00748 3/20 0.34
PLA2G6 O60733 1/20 0.34
ASAH1 Q13510 1/20 0.32
EPHX1 P07099 1/20 0.32
PPARG P37231 4/20 0.32
PPARD Q03181 4/20 0.32
PPARA Q07869 4/20 0.32
TSHR P16473 3/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL988084 0.95 HSD17B10 (0.41) HSD17B10GMNNTP53POLBMAPT
Hydrochloric Acid SCHEMBL1249049 0.94 HSD17B10 (0.40) HSD17B10GMNNTP53POLBMAPT
Ethylene SCHEMBL31337284 0.92 HSD17B10 (0.39) HSD17B10GMNNTP53POLBMAPT
SCHEMBL13730363 0.89 ALDH1A1 (0.39) HSD17B10GMNNTP53POLBMAPT
SCHEMBL17764215 0.88 BLM (0.36) HSD17B10GMNNTP53POLBMAPT
SCHEMBL14895466 0.85 ACHE (0.36) HSD17B10GMNNTP53POLBMAPT
SCHEMBL22438587 0.83 HSD17B10 (0.39) HSD17B10GMNNTP53POLBMAPT
SCHEMBL17642262 0.83 CES2 (0.41) HSD17B10GMNNTP53POLBMAPT
SCHEMBL10030122 0.82 ALDH1A1 (0.41) ALDH1A1TSHRHDAC11TDP1
SCHEMBL17556646 0.82 ALDH1A1 (0.34) HSD17B10GMNNTP53POLBMAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12258430-B2 Compositions and methods for labeling and modulation of cells in vitro and in vivo PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) 2025-03-25 US claimed
US-20240043369-A1 CROSSLINKING COMPOUNDS AND CROSSLINKED ACRYLIC POLYMERIC MATERIALS MASSACHUSETTS INSTITUTE OF TECHNOLOGY 2024-02-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12258430-B2 Compositions and methods for labeling and modulation of cells in vitro and in vivo CD47, LY6K, CD68 HSD17B10 4399/4885GMNN 229/4885TP53 185/4885
US-20240043369-A1 CROSSLINKING COMPOUNDS AND CROSSLINKED ACRYLIC POLYMERIC MATERIALS LIG3, AAAS, DCLRE1A HSD17B10 1250/4885GMNN 342/4885TP53 3062/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.